Precede Biosciences
57 employees
Biotech/Pharma
Series B · $132.0M
Company details
Team Size57
IndustryBiotech/Pharma
Funding
Total raised
$132.0M
Last stage
Series B
Investors
Illumina Ventures
Total raised
$132.0M
Last stage
Series B
Investors
Rehan Verjee
Founding CEO of Precede Biosciences. Previously a member of the Healthcare Executive Committee at Merck KGaA, serving as President of EMD Serono and Chief Marketing and Strategy Officer.
LinkedInSylvan Baca
Co-founder of Precede Biosciences. Research originated at the Dana-Farber Cancer Institute.
Matthew Freedman
Professor and co-founder of Precede Biosciences, affiliated with Dana-Farber Cancer Institute. Named to the David Goldstein Chair at Dana-Farber in support of kidney cancer research.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.